miR-409 Inhibits Human Non-Small-Cell Lung Cancer Progression by Directly Targeting SPIN1.

作者: Qi Song , Quanbo Ji , Jingbo Xiao , Fang Li , Lingxiong Wang

DOI: 10.1016/J.OMTN.2018.08.020

关键词: Tumor progressionCancerPI3K/AKT/mTOR pathwaymicroRNALung cancerCell migrationCarcinogenesisCancer researchMedicineProtein kinase B

摘要: Lung cancers, the leading cause of cancer mortality worldwide, are characterized by a high metastatic potential. Growing evidence reveals that Spindlin 1 (SPIN1) is involved in tumor progression and carcinogenesis. However, role SPIN1 non-small-cell lung (NSCLC) molecular mechanisms underlying human NSCLC remain undetermined. Here we examined function found expression was closely correlated with overall survival poor prognosis patients. Aberrant regulation microRNAs (miRNAs) has an important progression. We revealed miR-409 inhibits binding directly to 3′ UTR using dual-luciferase reporter assays. Overexpression significantly suppressed cell migration, growth, proliferation inhibiting in vitro in vivo. overexpression miR-409-transfected cells effectively rescued suppression regulated miR-409. regulates PI3K/AKT (protein kinase B) pathway NSCLC. Moreover, clinical data showed patients levels experienced better survival. also negatively associated expression. Taken together, these findings highlight miR-409/SPIN1 axis useful pleiotropic regulatory network could predict potential early, indicating possibility might be attractive prognostic markers for treating

参考文章(44)
Scott M. Hammond, An overview of microRNAs Advanced Drug Delivery Reviews. ,vol. 87, pp. 3- 14 ,(2015) , 10.1016/J.ADDR.2015.05.001
Henriette Franz, Holger Greschik, Dominica Willmann, Luka Ozretić, Cordula Annette Jilg, Eva Wardelmann, Manfred Jung, Reinhard Buettner, Roland Schüle, The histone code reader SPIN1 controls RET signaling in liposarcoma Oncotarget. ,vol. 6, pp. 4773- 4789 ,(2015) , 10.18632/ONCOTARGET.3000
Yi Yang, Lei Liu, Ying Zhang, Hongyu Guan, Jueheng Wu, Xun Zhu, Jie Yuan, Mengfeng Li, MiR-503 targets PI3K p85 and IKK-β and suppresses progression of non-small cell lung cancer International Journal of Cancer. ,vol. 135, pp. 1531- 1542 ,(2014) , 10.1002/IJC.28799
Ting Gang Chew, Anne Peaston, Ai Khim Lim, Chanchao Lorthongpanich, Barbara B. Knowles, Davor Solter, A Tudor Domain Protein SPINDLIN1 Interacts with the mRNA-Binding Protein SERBP1 and Is Involved in Mouse Oocyte Meiotic Resumption PLoS ONE. ,vol. 8, pp. e69764- ,(2013) , 10.1371/JOURNAL.PONE.0069764
Joshua T. Mendell, Eric N. Olson, MicroRNAs in Stress Signaling and Human Disease Cell. ,vol. 148, pp. 1172- 1187 ,(2012) , 10.1016/J.CELL.2012.02.005
Zhonghan Li, Tariq M. Rana, Therapeutic targeting of microRNAs: current status and future challenges Nature Reviews Drug Discovery. ,vol. 13, pp. 622- 638 ,(2014) , 10.1038/NRD4359
Heidi Schwarzenbach, Naohiro Nishida, George A. Calin, Klaus Pantel, Clinical relevance of circulating cell-free microRNAs in cancer Nature Reviews Clinical Oncology. ,vol. 11, pp. 145- 156 ,(2014) , 10.1038/NRCLINONC.2014.5
B Zheng, L Liang, S Huang, R Zha, L Liu, D Jia, Q Tian, Q Wang, C Wang, Z Long, Y Zhou, X Cao, C Du, Y Shi, X He, MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers Oncogene. ,vol. 31, pp. 4509- 4516 ,(2012) , 10.1038/ONC.2011.581
Kamesh R. Babu, Martina U. Muckenthaler, miR-20a regulates expression of the iron exporter ferroportin in lung cancer Journal of Molecular Medicine. ,vol. 94, pp. 347- 359 ,(2016) , 10.1007/S00109-015-1362-3
Rafael Rosell, Niki Karachaliou, Lung cancer in 2014: Optimizing lung cancer treatment approaches Nature Reviews Clinical Oncology. ,vol. 12, pp. 75- 76 ,(2015) , 10.1038/NRCLINONC.2014.225